...
首页> 外文期刊>European Chemical Bulletin >Cytotoxicity of novel 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives towards human tumor and normal cell lines and their uses as anti-leishmanial agents
【24h】

Cytotoxicity of novel 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives towards human tumor and normal cell lines and their uses as anti-leishmanial agents

机译:新型4,5,6,7-四氢苯并[b]噻吩衍生物对人肿瘤和正常细胞系的细胞毒性及其作为抗利什曼病制剂的用途

获取原文
           

摘要

This work has been carried out to investigate some reactions of 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives 1a,b to give synthesis a series of novel heterocyclic products like N-ethoxymethino derivatives ( 2a, 2b ), N-phenylaminomethino derivatives ( 3a, 3b ), hydrazine derivatives ( 5a-d ), pyrazole derivatives ( 7a-d, 10a-d, 11a, 11b ) and N-methinonitrilo derivatives ( 9a-d ). The antitumor evaluation of the newly synthesized compounds against the three human tumor cells lines namely breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268) showed that some of these compounds exhibit much higher inhibitory effects towards the three tumor cell lines than the positive control doxorubicin. Moreover, they were tested against normal cells namely diploid normal human fibroblast (WI-38), Normal prostate epithelial cells (PrEC) and normal human mucosal epithelial cells (NCM 460). The anti-leishmanial evaluations of the obtained compounds were also performed. Compounds 7d and 10b were the most active towards tumor cell lines while compounds 3a , 3b , 9b and 9d were the most active compounds as anti-leishmanial. Docking of these most active compounds is demonstrated.
机译:进行了这项工作以研究4,5,6,7-四氢苯并[b]噻吩衍生物1a,b的反应,从而合成了一系列新的杂环产物,如N-乙氧基次甲基衍生物(2a,2b),N-苯氨基次甲基衍生物(3a,3b),肼衍生物(5a-d),吡唑衍生物(7a-d,10a-d,11a,11b)和N-次甲基三腈衍生物(9a-d)。新合成的化合物对三种人类肿瘤细胞系,即乳腺癌(MCF-7),非小细胞肺癌(NCI-H460)和中枢神经系统癌(SF-268)的抗肿瘤评价表明,这些化合物中的一些表现出对三种肿瘤细胞系的抑制作用比阳性对照阿霉素高得多。此外,还针对正常细胞(即二倍体正常人成纤维细胞(WI-38),正常前列腺上皮细胞(PrEC)和正常人粘膜上皮细胞(NCM 460))进行了测试。还对所得化合物进行了抗利什曼分析。化合物7d和10b对肿瘤细胞系最具活性,而化合物3a,3b,9b和9d是抗利什曼肽的最具活性的化合物。证明了这些最活性化合物的对接。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号